[1] Lisman T, Porte RJ. Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases. Res Pract Thromb Haemost,2017,1:150-161.
[2] Rassi AB, D'Amico EA, Tripodi A, et al. Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: effect on conventional coagulation tests and thrombomodulin-modified thrombin generation. J Hepatol,2020,72:85-94.
[3] Mannucci PM, Tripodi A. Hemostatic defects in liver and renal dysfunction. Hematology Am Soc Hematol Educ Program, 2012,2012:168-173.
[4] Zwaginga JJ, IJsseldijk MH, Beester-Visser N, et al. High von Willebrand factor concentration compensates a relative adhesion defect in uremic blood. Blood,1990,75:1498-1508.
[5] Lisman T, Bongers TN, Adelmeijer J, et al. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology,2006,44:53-61.
[6] McCluskey SA, Karkouti K, Wijeysundera DN, et al. Derivation of a risk index for the prediction of massive blood transfusion in liver transplantation. Liver Transpl, 2006,12:1584-1593.
[7] Stravitz RT, Ellerbe C, Durkalski V, et al. Bleeding complications in acute liver failure. Hepatology,2018,67:1931-1942.
[8] Hung A, Garcia-Tsao G. Acute kidney injury, but not sepsis, is associated with higher procedure-related bleeding in patients with decompensated cirrhosis. Liver Int,2018,38:1437-1441.
[9] Zanetto A, Rinder HM, Campello E, et al. Acute kidney injury in decompensated cirrhosis is associated with both hypo- and hyper-coagulable features. Hepatology,2020,72:1327-1340.
[10] Potze W, Sanyal AJ, Lisman T. Reply to:Procoagulant imbalance in patients with non- alcoholic fatty liver disease. J Hepatol, 2017,66:250-251. |
